Pancreatic Cancer Research

ResearcherCentro de Química da MadeiraActive in the last 2 years

Xiangyang Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6785-6645; OpenAlex author ID A5055489694. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 4

  1. Biomimetic Dual-Driven Janus Nanorobots for Enhanced Penetration and Combined Gas/Photothermal/Photodynamic/Catalytic Therapy of Pancreatic Cancer. Co-author DOI 10.1021/acsnano.6c09872↗
  2. Exosome-Coated Dendrimer Nanogels as a Therapeutic Vaccine for CT Imaging-Guided Chemoimmunotherapy of Pancreatic Cancer. Last author DOI 10.1021/polymscitech.6c00065↗
  3. Redox-Responsive Dendrimer Nanogels Enable Ultrasound-Enhanced Chemoimmunotherapy of Pancreatic Cancer via Endoplasmic Reticulum Stress Amplification and Macro… Last author DOI 10.1002/advs.202301759↗
  4. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy. Co-author DOI 10.7150/thno.22834↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cheng Ni · 1 shared paper, 2026 · strength 0.32
  2. Rui Guo · 1 shared paper, 2026 · strength 0.32
  3. Zhuo Li · 1 shared paper, 2026 · strength 0.30
  4. Li Y · 1 shared paper, 2026 · strength 0.30
  5. Han Wang · 1 shared paper, 2023 · strength 0.17
  6. Guizhi Zhang · 1 shared paper, 2023 · strength 0.17
  7. Lianfang Du · 1 shared paper, 2018 · strength 0.08
  8. Feng Gao · 1 shared paper, 2018 · strength 0.08
  9. Peng Qin · 1 shared paper, 2018 · strength 0.08
  10. Lizhou Lin · 1 shared paper, 2018 · strength 0.08
  11. Fan Li · 1 shared paper, 2018 · strength 0.08
  12. Dan Li · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.